Perceptive Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,024,400
| Closed | -$95.1M | – | 121 |
|
|
2023
Q4 | $95.1M | Sell |
4,024,400
-18,791
| -0.5% | -$444K | 2.12% | 11 |
|
|
2023
Q3 | $60.3M | Buy |
4,043,191
+309,936
| +8% | +$4.62M | 2.01% | 14 |
|
|
2023
Q2 | $40.9M | Sell |
3,733,255
-170,000
| -4% | -$1.86M | 1.18% | 26 |
|
|
2023
Q1 | $34M | Buy |
3,903,255
+3,194,262
| +451% | +$27.9M | 1% | 32 |
|
|
2022
Q4 | $4.45M | Buy |
+708,993
| New | +$4.45M | 0.12% | 71 |
|
|
2019
Q4 | – | Sell |
-1,520,355
| Closed | -$7.78M | – | 123 |
|
|
2019
Q3 | $7.78M | Sell |
1,520,355
-2,342,466
| -61% | -$12M | 0.21% | 60 |
|
|
2019
Q2 | $27.7M | Sell |
3,862,821
-350,000
| -8% | -$2.51M | 0.63% | 40 |
|
|
2019
Q1 | $55.9M | Buy |
4,212,821
+1,750,000
| +71% | +$23.2M | 1.58% | 19 |
|
|
2018
Q4 | $19.4M | Sell |
2,462,821
-280,000
| -10% | -$2.2M | 0.74% | 36 |
|
|
2018
Q3 | $30.4M | Hold |
2,742,821
| – | – | 0.81% | 39 |
|
|
2018
Q2 | $36.8M | Sell |
2,742,821
-60,000
| -2% | -$805K | 0.97% | 32 |
|
|
2018
Q1 | $33.7M | Buy |
2,802,821
+116,939
| +4% | +$1.41M | 0.95% | 27 |
|
|
2017
Q4 | $24.7M | Buy |
2,685,882
+335,000
| +14% | +$3.08M | 0.82% | 29 |
|
|
2017
Q3 | $18.9M | Buy |
+2,350,882
| New | +$18.9M | 0.72% | 33 |
|